BRIEF published on 08/29/2024 at 17:50, 1 year 8 months ago Median Technologies : eyonis atteint les objectifs de l'étude REALITY Dépistage Median Technologies Cancer Du Poumon Eyonis™ LCS AUC
BRIEF published on 08/29/2024 at 17:50, 1 year 8 months ago Median Technologies: eyonis achieves REALITY study objectives Screening Median Technologies Lung Cancer Eyonis™ LCS AUC
PRESS RELEASE published on 08/29/2024 at 17:45, 1 year 8 months ago Informations privilégiées / Autres communiqués Median Technologies annonce que l'étude pivot REALITY évaluant eyonis™ LCS dans le dépistage du cancer du poumon répond à tous les critères d'évaluation primaire et secondaires Dépistage Median Technologies Cancer Du Poumon Eyonis LCS Étude Pivot
BRIEF published on 07/18/2024 at 18:01, 1 year 10 months ago Median Technologies dévoile des résultats semestriels et des avancées stratégiques Chiffre D'affaires Intelligence Artificielle Carnet De Commandes ICRO Eyonis™ LCS
BRIEF published on 07/18/2024 at 18:01, 1 year 10 months ago Median Technologies unveils half-year results and strategic advances Artificial Intelligence Turnover Backlog ICRO Eyonis™ LCS
PRESS RELEASE published on 07/18/2024 at 17:56, 1 year 10 months ago Informations privilégiées / Communiqué sur comptes, résultats Median Technologies annonce un carnet de commandes record et les résultats de l'étude eyonis LCS. Chiffre d'affaires semestriel à 10,9 m€, vision et opportunités de croissance en iCRO. Webcast avec le CEO le 24/07/2024 Chiffre D'affaires Carnet De Commandes Median Technologies ICRO Eyonis LCS
PRESS RELEASE published on 07/18/2024 at 17:56, 1 year 10 months ago Inside Information / News release on accounts, results Median Technologies reports record iCRO backlog and eyonis™ LCS on-track for pivotal study readout in August. Revenue at €10.9 million, cash at €16 million. CEO to provide update via webcast on July 24, 2024 Revenue Growth Median Technologies ICRO Eyonis LCS Pivotal Study
BRIEF published on 06/07/2024 at 17:50, 1 year 11 months ago Changes in Shareholder Voting Rights at Median Technologies Share Capital Voting Rights French Regulations Median Technologies Non-voting Shares
BRIEF published on 06/07/2024 at 17:50, 1 year 11 months ago Modifications des droits de vote des actionnaires chez Median Technologies Droit De Vote Partage Le Capital Technologies Médianes Actions Sans Droit De Vote Réglementation Française
PRESS RELEASE published on 06/07/2024 at 17:45, 1 year 11 months ago Changes in the rights attaching to the classes of shares or securities Median Technologies discloses total voting rights and share capital as of May 31, 2024, in compliance with French regulations. The company specializes in AI-driven solutions for cancer diagnosis and treatment Share Capital Voting Rights AI Solutions Median Technologies Cancer Diagnosis
Published on 05/23/2026 at 01:00, 23 minutes ago LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Published on 05/23/2026 at 00:55, 28 minutes ago GLG Life Tech Corporation Reports 2026 First Quarter Financial Results
Published on 05/23/2026 at 00:15, 1 hour 8 minutes ago Molten Metals Completes Airborne Geophysical Survey at Texas Project
Published on 05/23/2026 at 00:00, 1 hour 23 minutes ago Redwood AI Announces Collaboration with Resilience Biosciences Inc. to Advance AI-Assisted Small-Molecule Drug Development
Published on 05/22/2026 at 22:05, 3 hours 18 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 3 hours 18 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 5 hours 32 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 6 hours 50 minutes ago Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 6 hours 53 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 19:35, 5 hours 48 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 7 hours 17 minutes ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 7 hours 17 minutes ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 12 hours 30 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 12 hours 30 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
